Pharming Group N.V. PHAR

Full chart Compare
Set alert

Price alert · PHAR

All alert types
12.13 USD -0.33 (-2.65%)

Nov 5, 2026, 9:46 AM EST

12.13 Day range 12.40
9.11 52-week range 21.34
YTD
-31.35%
1 year
-7.97%

Revenue & Expenses

Revenue → Gross Profit: $330.63MGross Profit → Net Income: $2.85MGross Profit → Selling, General & Admin: $117.44MGross Profit → Research & Development: $100.37MRevenue → Cost of Revenue: $45.50MGross Profit → Other Operating Expenses: $91.95MGross Profit → Other Expenses: $7.72MGross Profit → Income Tax: $10.31MGross Profit$330.63MCost of Revenue$45.50MNet Income$2.85MSelling, General & Admin$117.44MResearch & Development$100.37MOther Operating Expenses$91.95MOther Expenses$7.72MIncome Tax$10.31MRevenue$376.13M

Latest period ending Dec 31, 2025 · select a line to chart its full history

PHAR annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
376.13M297.20M245.32M205.62M198.87M
330.63M261.80M220.10M188.06M177.73M
25.84M-8.62M-5.39M18.23M13.56M
2.85M-11.84M-10.55M13.67M16.00M
0.04-0.18-0.160.190.23
PHAR annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
146.07M54.94M61.74M207.56M192.15M
499.96M399.99M462.85M425.80M397.31M
222.86M178.92M244.07M221.16M204.40M
115.78M112.31M171.54M166.69M161.93M
277.10M221.06M218.78M204.64M192.92M
PHAR annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
54.71M-1.79M-17.30M22.46M37.84M
26.25M31.62M-129.39M5.32M-21.30M
1.50M-34.41M-1.04M-4.98M-27.95M
-749.00K-790.00K-1.44M-1.38M-10.74M
82.45M-4.59M-147.73M22.80M-11.41M